Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 16.86%621.15B | 18.07%589.41B | 15.87%519.52B | 16.14%2.02T | 14.33%539.49B | 17.65%531.54B | 15.02%499.19B | 17.89%448.34B | 16.00%1.74T | 20.73%471.88B |
Cost of revenue | 5.74%166.53B | 8.82%164.41B | 10.99%151.8B | 7.33%611.22B | 16.41%165.87B | 3.12%157.49B | 2.12%151.09B | 8.26%136.78B | 15.04%569.5B | 4.49%142.49B |
Gross profit | 21.54%454.62B | 22.09%425B | 18.02%367.72B | 20.44%1.41T | 13.43%373.62B | 25.07%374.05B | 21.69%348.11B | 22.68%311.57B | 16.47%1.17T | 29.43%329.39B |
Operating expense | 12.12%315.29B | 10.53%297.98B | 17.79%282.96B | 13.56%1.12T | 13.84%324.65B | 14.31%281.21B | 12.56%269.6B | 13.45%240.22B | 15.47%982.43B | 11.15%285.18B |
Selling and administrative expenses | 18.04%241.33B | 21.98%239.97B | 21.75%213.75B | 11.49%807.36B | 14.86%230.63B | 11.15%204.45B | 6.39%196.73B | 13.63%175.56B | 16.36%724.13B | 9.53%200.79B |
-General and administrative expense | 18.04%241.33B | 21.98%239.97B | 21.75%213.75B | 11.49%807.36B | 14.86%230.63B | 11.15%204.45B | 6.39%196.73B | 13.63%175.56B | 16.36%724.13B | 9.53%200.79B |
Research and development costs | 3.62%76.2B | -3.47%71.56B | 6.50%72.39B | 11.84%307.8B | 13.14%92.17B | 7.26%73.53B | 12.56%74.13B | 14.53%67.97B | 18.48%275.23B | 16.75%81.47B |
Other operating expenses | -83.47%771M | -51.18%228M | -21.75%421M | -4.11%6.25B | -38.80%3.4B | 943.18%4.66B | 74.25%467M | 119.59%538M | -13.08%6.52B | 30.85%5.56B |
Total other operating income | 110.64%3.01B | 696.13%13.78B | -6.39%3.6B | -75.56%5.73B | -41.44%1.54B | -79.37%1.43B | -84.99%1.73B | 63.19%3.85B | 106.60%23.45B | 238.87%2.63B |
Operating profit | 50.08%139.33B | 61.79%127.02B | 18.79%84.76B | 56.76%291.67B | 10.76%48.97B | 74.94%92.84B | 68.67%78.51B | 68.94%71.35B | 22.03%186.06B | 2,236.93%44.21B |
Net non-operating interest income (expenses) | -967.33%-20.95B | 38.37%7.86B | 227.16%8.06B | -86.55%3.04B | 11.81%-7.52B | -56.16%2.42B | -63.14%5.68B | -75.94%2.46B | 147.57%22.63B | -984.84%-8.52B |
Non-operating interest income | -400.52%-12.06B | 52.71%10.49B | 159.84%10.09B | -66.66%9.57B | 23.12%-4.99B | -42.86%4.01B | -59.66%6.87B | -65.54%3.88B | 105.23%28.69B | -321.68%-6.48B |
Non-operating interest expense | 456.07%8.89B | 121.19%2.63B | 43.14%2.03B | 7.59%6.52B | 24.20%2.53B | 5.55%1.6B | -26.47%1.19B | 37.16%1.42B | 25.27%6.06B | 3.82%2.04B |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 52.63%11.24B | 171.60%11.19B | 30.98%7.39B | 252.34%20.37B | 55.47%3.24B | 655.38%7.37B | 1,004.29%4.12B | 140.41%5.64B | -32.06%5.78B | 1,632.35%2.08B |
Special income (charges) | 44.06%-15.8B | -261.97%-103.95B | 40.76%-125M | -315.26%-172.42B | -964.74%-115.25B | -345.46%-28.24B | -5,380.53%-28.72B | 99.11%-211M | -540.86%-41.52B | -657.98%-10.82B |
Less:Write off | -44.06%15.8B | 261.97%103.95B | -40.76%125M | 315.26%172.42B | 964.74%115.25B | 345.46%28.24B | 5,380.53%28.72B | -99.11%211M | 540.86%41.52B | 657.98%10.82B |
Other non-operating income (expenses) | ||||||||||
Income before tax | 53.04%113.82B | -29.32%42.12B | 26.30%100.08B | -17.52%142.66B | -361.74%-70.55B | 39.77%74.37B | -3.58%59.59B | 155.74%79.24B | 5.69%172.95B | 1,109.55%26.96B |
Income tax | 108.68%29.46B | -39.59%10.39B | 27.76%21.18B | -51.91%17.16B | -947.97%-30.74B | 30.93%14.12B | 18.94%17.2B | 143.59%16.58B | 3.61%35.67B | 296.37%3.63B |
Net income | 40.00%84.36B | -25.16%31.73B | 25.91%78.9B | -8.58%125.5B | -270.66%-39.81B | 42.02%60.26B | -10.46%42.4B | 159.17%62.66B | 6.25%137.28B | 2,931.31%23.33B |
Net income continuous operations | 40.00%84.36B | -25.16%31.73B | 25.91%78.9B | -8.58%125.5B | -270.66%-39.81B | 42.02%60.26B | -10.46%42.4B | 159.16%62.66B | 6.25%137.28B | 2,931.31%23.33B |
Noncontrolling interests | -57.66%481M | 6.42%1.31B | 23.21%1.52B | 15.12%3.88B | -38.34%283M | -2.07%1.14B | 49.21%1.23B | 32.76%1.23B | -9.93%3.37B | 27.15%459M |
Net income attributable to the company | 41.88%83.88B | -26.10%30.42B | 25.96%77.38B | -9.18%121.62B | -275.33%-40.1B | 43.26%59.12B | -11.52%41.16B | 164.22%61.43B | 6.73%133.91B | 2,029.96%22.87B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 41.88%83.88B | -26.10%30.42B | 25.96%77.38B | -9.18%121.62B | -275.33%-40.1B | 43.26%59.12B | -11.52%41.16B | 164.22%61.43B | 6.73%133.91B | 2,029.96%22.87B |
Gross dividend payment | ||||||||||
Basic earnings per share | 42.04%154.72 | -26.13%56.03 | 25.96%142.59 | -9.20%224.1 | -275.34%-73.89 | 43.25%108.93 | -11.53%75.85 | 164.12%113.2 | 6.69%246.8 | 2,033.03%42.14 |
Diluted earnings per share | 42.04%154.72 | -26.13%56.03 | 25.99%142.59 | -9.19%224.1 | -275.34%-73.89 | 43.29%108.93 | -11.48%75.85 | 165.06%113.18 | 6.76%246.78 | 2,024.20%42.14 |
Dividend per share | 0 | 20.00%60 | 0 | 10.00%110 | 20.00%60 | 0 | 0.00%50 | 0 | 0.00%100 | 0.00%50 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |